Buy Stocks Easy | About Us

September 27, 2022

AFMD

Buy Affimed N.V. Stock (symbol: AFMD) Easy Online

Company Name: Affimed N.V.

Symbol: AFMD

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

AFMD Current Share Price

Today's AFMD ( Affimed N.V. ) opening price: $2.7400

Yesterday's AFMD ( Affimed N.V. ) closing price: $2.7400

Affimed N.V. Stock ( symbol: AFMD ) Price Chart since IPO (2014):

12 Months Affimed N.V. Stock ( symbol: AFMD ) Price Chart

Popular Questions about Affimed N.V. Public Stock ( AFMD )

A: Affimed N.V. stock symbol (also called stock or share ticker) is AFMD

A: Affimed N.V. IPO (Initial Public Offering) took place on 2014

A: Affimed N.V.'s stock (AFMD symbol) price at ther IPO (initial Public Offering) was $2.7400

Q: Is AFMD stock worth buying at the moment?

A: The AFMD stock performance since 2019 are rather disappointing. If you had bought 1 share of Affimed N.V. stock (symbol: AFMD) at the beginning of 2019, at the opening share price of $3.4300, you would be left with exactly $2.7400 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Affimed N.V. Stock Easy Online

Affimed N.V. Stock Ticker Price Chart since IPO:

Affimed N.V. Stock Price Yesterday

Affimed N.V. Stock Price – Last Week

Affimed N.V. Stock Price – Last Month

Affimed N.V. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.globenewswire.com/news-release/2019/12/17/1961486/0/en/Affimed-Announces-Addition-to-NASDAQ-Biotechnology-Index.html

Affimed Announces Addition to NASDAQ Biotechnology Index

Heidelberg, Germany, December 17, 2019 – Affimed N.V. (Nasdaq: AFMD...

https://seekingalpha.com/article/4307819-affimed-n-v-afmd-ceo-adi-hoess-q3-2019-results-earnings-call-transcript

Affimed N.V. (AFMD) CEO Adi Hoess on Q3 2019 Results - Earnings Call Transcript

Affimed N.V. (AFMD) CEO Adi Hoess on Q3 2019 Results - Earnings Cal...

http://www.zacks.com/stock/news/627218/affimed-nv-afmd-reports-q3-loss-misses-revenue-estimates

Affimed N.V. (AFMD) Reports Q3 Loss, Misses Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of -35...

http://www.globenewswire.com/news-release/2019/11/19/1949355/0/en/Affimed-Reports-Third-Quarter-2019-Financial-Results-and-Recent-Operational-Progress.html

Affimed Reports Third Quarter 2019 Financial Results and Recent Operational Progress

FOR IMMEDIATE RELEASE

http://www.globenewswire.com/news-release/2019/11/14/1947049/0/en/Affimed-to-Present-at-the-Jefferies-2019-London-Healthcare-Conference.html

Affimed to Present at the Jefferies 2019 London Healthcare Conference

Heidelberg, Germany, November 14, 2019 – Affimed N.V. (Nasdaq: AFMD...

http://www.globenewswire.com/news-release/2019/11/14/1947050/0/en/Affimed-Announces-Third-Quarter-2019-Financial-Results-and-Corporate-Update-Conference-Call-on-November-19-2019.html

Affimed Announces Third Quarter 2019 Financial Results and Corporate Update Conference Call on November 19, 2019

Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical co...

http://www.globenewswire.com/news-release/2019/11/13/1946730/0/en/Affimed-Announces-Closing-of-Public-Offering-of-Common-Shares-and-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html

Affimed Announces Closing of Public Offering of Common Shares and Exercise of Underwriters’ Option to Purchase Additional Shares

FOR IMMEDIATE RELEASE

http://www.globenewswire.com/news-release/2019/11/08/1943905/0/en/Affimed-Announces-Pricing-of-Public-Offering-of-Common-Shares.html

Affimed Announces Pricing of Public Offering of Common Shares

Heidelberg, Germany, November 8, 2019 – Affimed N.V. (“Affimed” or ...

http://www.globenewswire.com/news-release/2019/11/07/1943585/0/en/Affimed-Announces-Proposed-Public-Offering-of-Common-Shares.html

Affimed Announces Proposed Public Offering of Common Shares

Heidelberg, Germany, November 7, 2019 – Affimed N.V. (“Affimed” or ...

http://www.globenewswire.com/news-release/2019/11/07/1943484/0/en/Affimed-Highlights-Progress-on-NK-Cell-Engager-Collaboration-with-Genentech.html

Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech

Heidelberg, Germany, November 7, 2019 - Affimed N.V. (Nasdaq: AFMD)...

All right reserved Buy Stocks Easy , 2019.